Primary |
Hypercholesterolaemia |
21.2% |
Hyperlipidaemia |
18.5% |
Acute Coronary Syndrome |
14.4% |
Blood Cholesterol Increased |
13.7% |
Hypertension |
5.5% |
Diabetes Mellitus |
2.7% |
Product Used For Unknown Indication |
2.7% |
Angina Pectoris |
2.1% |
Dyslipidaemia |
2.1% |
Erectile Dysfunction |
2.1% |
Gout |
2.1% |
Infection |
2.1% |
Psoriasis |
2.1% |
Atrial Fibrillation |
1.4% |
Blood Cholesterol |
1.4% |
Essential Hypertension |
1.4% |
Osteoporosis Prophylaxis |
1.4% |
Rheumatoid Arthritis |
1.4% |
Type Iia Hyperlipidaemia |
1.4% |
Anxiety |
0.7% |
|
Myalgia |
18.9% |
Rhabdomyolysis |
15.1% |
Muscular Weakness |
7.5% |
Neutropenia |
7.5% |
Blood Creatine Phosphokinase Increased |
5.7% |
Pain In Extremity |
3.8% |
Pancreatitis Acute |
3.8% |
Pulmonary Embolism |
3.8% |
Rash |
3.8% |
Renal Failure Acute |
3.8% |
Thrombocytopenia |
3.8% |
Tremor |
3.8% |
Vitreous Detachment |
3.8% |
Vomiting |
3.8% |
Abdominal Pain |
1.9% |
Acute Coronary Syndrome |
1.9% |
Alopecia |
1.9% |
Alopecia Totalis |
1.9% |
Aspartate Aminotransferase Increased |
1.9% |
Blood Creatinine Increased |
1.9% |
|
Secondary |
Product Used For Unknown Indication |
24.8% |
Drug Use For Unknown Indication |
21.2% |
Blood Cholesterol Increased |
12.8% |
Hyperlipidaemia |
11.5% |
Hypercholesterolaemia |
7.3% |
Hypertension |
5.1% |
Lipid Metabolism Disorder |
2.2% |
Dyslipidaemia |
2.0% |
Hiv Infection |
1.5% |
Congestive Cardiomyopathy |
1.4% |
Antiplatelet Therapy |
1.2% |
Atrial Fibrillation |
1.2% |
High Density Lipoprotein Decreased |
1.1% |
Type 2 Diabetes Mellitus |
1.1% |
Gout |
1.0% |
Type Iia Hyperlipidaemia |
1.0% |
Blood Cholesterol |
1.0% |
Completed Suicide |
0.9% |
Epilepsy |
0.9% |
Angina Pectoris |
0.8% |
|
Rhabdomyolysis |
14.0% |
Completed Suicide |
13.1% |
Amyotrophic Lateral Sclerosis |
7.2% |
Ventricular Tachycardia |
7.2% |
Paraesthesia |
6.8% |
Sleep Disorder |
6.3% |
Death |
5.0% |
Renal Failure Acute |
5.0% |
Stevens-johnson Syndrome |
4.1% |
Weight Decreased |
4.1% |
Depression |
3.6% |
Thrombocytopenia |
3.6% |
Dyspnoea Exertional |
2.7% |
Liver Function Test Abnormal |
2.7% |
Myalgia |
2.7% |
Systemic Lupus Erythematosus |
2.7% |
Liver Disorder |
2.3% |
Myopathy |
2.3% |
Pancreatitis Acute |
2.3% |
Respiratory Arrest |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
29.4% |
Drug Use For Unknown Indication |
24.6% |
Hypertension |
9.5% |
Type 2 Diabetes Mellitus |
4.2% |
Rheumatoid Arthritis |
3.6% |
Blood Cholesterol Increased |
3.6% |
Diabetes Mellitus |
3.3% |
Prophylaxis |
2.7% |
Hypercholesterolaemia |
2.4% |
Pain |
2.4% |
Hiv Infection |
2.2% |
Hyperlipidaemia |
2.0% |
Blood Cholesterol |
1.6% |
Atrial Fibrillation |
1.5% |
Depression |
1.5% |
Osteoporosis |
1.3% |
Multiple Myeloma |
1.2% |
Thrombosis Prophylaxis |
1.0% |
Gastrooesophageal Reflux Disease |
1.0% |
Cardiac Disorder |
0.9% |
|
Vomiting |
9.7% |
Renal Failure Acute |
7.3% |
Weight Decreased |
7.0% |
Rhabdomyolysis |
6.6% |
Hypoglycaemia |
5.5% |
Tremor |
5.5% |
Flushing |
5.2% |
Thrombocytopenia |
5.2% |
Myocardial Infarction |
4.5% |
Pain In Extremity |
4.5% |
Renal Failure |
4.5% |
Pruritus |
4.1% |
Urticaria |
4.1% |
Weight Increased |
4.1% |
Dyspnoea |
3.9% |
Malaise |
3.9% |
Hypotension |
3.8% |
White Blood Cell Count Decreased |
3.8% |
Death |
3.6% |
Myalgia |
3.2% |
|
Interacting |
Blood Cholesterol Increased |
11.1% |
Hyperlipidaemia |
11.1% |
Hypercholesterolaemia |
8.9% |
Immunosuppression |
6.7% |
Pain In Extremity |
6.7% |
Parkinson's Disease |
6.7% |
Atrial Fibrillation |
4.4% |
Bipolar I Disorder |
4.4% |
Cardiovascular Event Prophylaxis |
4.4% |
Diabetes Mellitus |
4.4% |
Erectile Dysfunction |
4.4% |
Hypertension |
4.4% |
Immunosuppressant Drug Therapy |
4.4% |
Product Used For Unknown Indication |
4.4% |
Benign Prostatic Hyperplasia |
2.2% |
Blood Cholesterol Abnormal |
2.2% |
Bronchitis |
2.2% |
Dyslipidaemia |
2.2% |
Epilepsy |
2.2% |
Mental Disorder |
2.2% |
|
Drug Interaction |
18.2% |
Pain In Extremity |
9.1% |
Renal Failure Acute |
9.1% |
Rhabdomyolysis |
9.1% |
Vertigo |
9.1% |
Acidosis |
4.5% |
Erectile Dysfunction |
4.5% |
Erythema Nodosum |
4.5% |
Lipids Abnormal |
4.5% |
Mobility Decreased |
4.5% |
Musculoskeletal Stiffness |
4.5% |
Nephrolithiasis |
4.5% |
Rectal Haemorrhage |
4.5% |
Transplant Rejection |
4.5% |
Vestibular Disorder |
4.5% |
|